Screener
HealthEquity HQY Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Repurchases of common stock | (123,314) | (59,065) |
| Principal payments on long-term debt | (15,000) | — |
| Settlement of client-held funds obligation, net | 716 | 1,451 |
| Proceeds from exercise of common stock options | 418 | 965 |
| Net cash used in financing activities | (137,180) | (56,649) |
| Decrease in cash and cash equivalents | (53,558) | (8,054) |
| Beginning cash and cash equivalents | 318,927 | 295,948 |
| Ending cash and cash equivalents | $265,369 | $287,894 |
Item 1. Financial statements
FAQ
- What is HealthEquity's net change in cash?
- HealthEquity (HQY) reported net change in cash of -$53.56M in Q1 2026.
- How has HealthEquity's net change in cash changed year-over-year?
- HealthEquity's net change in cash decreased by 565.0% year-over-year, from -$8.05M to -$53.56M.
- What is the long-term trend for HealthEquity's net change in cash?
- Over 2 years (2022 to 2026), HealthEquity's net change in cash has grown at a -52.9% compound annual growth rate (CAGR), from -$103.39M to $22.98M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about HealthEquity's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude